Literature DB >> 9066026

Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines.

M Sakaguchi1, M Yoshida, W Kuroda, O Harayama, Y Matsunaga, S Inouye.   

Abstract

Three children had systemic immediate-type reactions to Japanese encephalitis (JE) vaccine which contains gelatin as a stabilizer. We found that all the children had anti-gelatin IgE in their sera. Further, two of the three also had experienced systemic allergic reactions to gelatin-containing foods before the vaccination. We assume that the systemic allergic reactions to JE vaccines might be caused by gelatin in the JE vaccine.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9066026     DOI： 10.1016/s0264-410x(96)00170-3

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  10 in total

1.  Reactivity of the immunoglobulin E in bovine gelatin-sensitive children to gelatins from various animals.

Authors:  M Sakaguchi; H Hori; T Ebihara; S Irie; M Yanagida; S Inouye
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

2.  A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice.

Authors:  G J Chang; A R Hunt; B Davis
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.

Authors:  Manisha Saini; Sudhanshu Vrati
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 4.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

5.  Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.

Authors:  Ingrid B Rabe; Elaine R Miller; Marc Fischer; Susan L Hills
Journal:  Vaccine       Date:  2014-12-09       Impact factor: 3.641

6.  Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.

Authors:  Zijiang Zhao; Takaji Wakita; Kotaro Yasui
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.

Authors:  Yongzhen Zhai; Yan Zhou; Ximei Li; Guohe Feng
Journal:  Mol Med Rep       Date:  2015-03-04       Impact factor: 2.952

8.  International Consensus (ICON): allergic reactions to vaccines.

Authors:  Stephen C Dreskin; Neal A Halsey; John M Kelso; Robert A Wood; Donna S Hummell; Kathryn M Edwards; Jean-Christoph Caubet; Renata J M Engler; Michael S Gold; Claude Ponvert; Pascal Demoly; Mario Sanchez-Borges; Antonella Muraro; James T Li; Menachem Rottem; Lanny J Rosenwasser
Journal:  World Allergy Organ J       Date:  2016-09-16       Impact factor: 4.084

9.  Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.

Authors:  Pushpa Ranjan Wijesinghe; M R Nihal Abeysinghe; Sutee Yoksan; Yafu Yao; Benli Zhou; Lei Zhang; Jessica A Fleming; Anthony A Marfin; John C Victor
Journal:  Vaccine       Date:  2016-10-20       Impact factor: 3.641

10.  Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.

Authors:  William L Walker; Susan L Hills; Elaine R Miller; Marc Fischer; Ingrid B Rabe
Journal:  Vaccine       Date:  2018-06-08       Impact factor: 3.641
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.